Campus Construction Update

As part of our work to ensure the look of our campus matches the exceptional care you've come to expect, we're closing the corridor between the Moakley and Menino lobbies for approximately one month, starting on Saturday, Aug. 10. Thank you for your patience during this time.

Click here to learn more about our campus redesign. 

Sickle Cell Disease

Treatments and Services

BMC offers all treatments and therapies for sickle cell disease, including:

  • Gene therapies: Boston Medical Center is the only hospital in New England to offer transformative gene therapy to eligible adults with sickle cell disease. We offer both FDA-approved gene therapies for sickle cell disease, Casgevy and Lyfegenia.
  • Hydroxyurea
  • L-glutamine
  • Voxelotor
  • Crizanlizumab
  • Blood transfusions
  • Pain medications
  • Bone marrow transplant